Movicol Schokoladengeschmack (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350, a high‑molecular‑weight polyethylene glycol, is not absorbed from the gut. It creates an osmotic gradient that draws water into the intestinal lumen, softening stool and stimulating peristalsis, while the added electrolytes help maintain fluid balance.

The dose of Movicol Schokoladengeschmack is individualized by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. The prescriber determines the appropriate volume and frequency of the oral solution.

Safety data for Movicol Schokoladengeschmack in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made in consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives such as bisacodyl, Movicol Schokoladengeschmack works by osmotic water retention rather than stimulating intestinal muscle directly, often resulting in a gentler, more predictable softening of stool. It is also comparable to other polyethylene glycol‑based solutions but includes electrolytes to help maintain fluid balance.

Store the oral solution at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture and direct heat, and ensure the cap is tightly closed to maintain product stability.

The product is taken orally as a measured dose of the clear solution. It can be consumed directly or mixed with a small amount of water, juice, or other non‑carbonated beverage to improve palatability, following the prescriber’s instructions.

Serious risks include electrolyte disturbances such as hyponatremia or hypokalemia, severe dehydration, and rare allergic reactions that may present as rash, angioedema, or anaphylaxis. Patients should be monitored for these signs, especially if they have underlying renal or cardiac conditions.

The product should be avoided in individuals with known hypersensitivity to any component, severe renal impairment, intestinal obstruction, or perforation. Caution is also advised for patients with congestive heart failure or uncontrolled electrolyte disorders.